Natixis Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
+27,052
New +$261K ﹤0.01% 1746
2025
Q2
Sell
-24,085
Closed -$229K 1671
2025
Q1
$229K Sell
24,085
-12,891
-35% -$161K ﹤0.01% 1592
2024
Q4
$609K Buy
36,976
+2,994
+9% +$46.5K ﹤0.01% 1427
2024
Q3
$501K Buy
33,982
+11,936
+54% +$187K ﹤0.01% 1453
2024
Q2
$306K Sell
22,046
-8,600
-28% -$122K ﹤0.01% 1518
2024
Q1
$482K Sell
30,646
-8,714
-22% -$135K ﹤0.01% 1404
2023
Q4
$636K Buy
39,360
+20,010
+103% +$327K ﹤0.01% 1337
2023
Q3
$238K Sell
19,350
-2,212
-10% -$32.9K ﹤0.01% 1466
2023
Q2
$347K Buy
21,562
+4,957
+30% +$81.7K ﹤0.01% 1414
2023
Q1
$289K Buy
+16,605
New +$237K ﹤0.01% 1413
2022
Q1
Sell
-12,844
Closed -$438K 1456
2021
Q4
$438K Sell
12,844
-14,284
-53% -$559K ﹤0.01% 1262
2021
Q3
$1.31M Buy
27,128
+9,668
+55% +$448K 0.01% 1033
2021
Q2
$789K Sell
17,460
-2,780
-14% -$123K ﹤0.01% 1140
2021
Q1
$976K Buy
20,240
+8,921
+79% +$464K 0.01% 1066
2020
Q4
$609K Buy
+11,319
New +$511K ﹤0.01% 1100

Other funds holding NEO

Natixis Advisors's NEO Position: Q2 2026 in Review

Natixis Advisors opened a new position in NeoGenomics (NEO) in Q2 2026: 27,052 shares worth $394K. The stake represents ﹤0.01% of the portfolio and ranks #1746 among its holdings. This is a return to the name: Natixis Advisors previously reported a position in NEO as recently as Q1 2025.

Natixis Advisors first reported a position in NEO in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.31M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Natixis Advisors held 27,052 shares of NeoGenomics worth $394K as of Q2 2026.
  • NeoGenomics was a new Natixis Advisors position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1746 holding.
  • Natixis Advisors first reported a position in NeoGenomics in Q4 2020 and has held it in 15 quarters since.
  • Natixis Advisors's NeoGenomics position peaked at $1.31M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.